Corin names Stefano Alfonsi as CEO, Chairman

Hip and knee replacement specialist Corin has named Stefano Alfonsi as its new Chief Executive Officer and acting Chairman.

The appointment follows the group's takeover by investment vehicle 2IL Orthopaedics in a 70p per share cash offer valuing the company at around £30.5m.

Corin confirmed that Peter Huntley, Linda Wilding and David Young have all resigned.

Start your trial of MoneyWeek today

Get unparalleled financial insight, analysis and expert opinion you can profit from.

Start your trial

Sign up for MoneyWeek’s free twice-daily newsletter.

Join more than 165,000 subscribers and keep yourself informed with latest financial news, insights and expert analysis to help you understand what really matters when it comes to your finances.

Join more than 165,000 subscribers and keep yourself informed with latest financial news, insights and expert analysis to help you understand what really matters when it comes to your finances.

Sign up

Marco Fumagalli, Enrico Amo and Pierluca Antolini, all of whom are directors at 2IL Orthopaedics, have been appointed to the board of Corin as non-executive directors.

Stefano Alfonsi, who will start work at Corin following a short transitional period, is currently employed by the medical devices company Inion.

Alfonsi has also held senior positions at Johnson and Johnson, DePuy and Covidien and most recently as Chief Executive Officer of Lima.

CJ